Variant report

Variant	esv994460
Chromosome Location	chr6:37672682-37686270
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:15)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:15 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:37677399..37679341-chr6:37680360..37683613,3	MCF-7	breast:
2	chr6:37669043..37673675-chr6:37673911..37678816,5	K562	blood:
3	chr6:37668297..37671248-chr6:37671352..37673734,2	K562	blood:
4	chr6:37666148..37667769-chr6:37674734..37677605,2	K562	blood:
5	chr6:37679512..37681252-chr6:37684864..37686953,2	K562	blood:
6	chr6:37679084..37680662-chr6:37692343..37694069,2	K562	blood:
7	chr6:37679512..37681252-chr6:37684864..37686953,2	K562	blood:
8	chr6:37670172..37672824-chr6:37782516..37784751,2	K562	blood:
9	chr6:37666178..37668975-chr6:37671383..37675389,6	K562	blood:
10	chr6:37685535..37687713-chr6:37690010..37691787,2	MCF-7	breast:
11	chr6:37677399..37679341-chr6:37680360..37683613,3	MCF-7	breast:
12	chr6:37669043..37673675-chr6:37673911..37678816,5	K562	blood:
13	chr6:37678322..37680525-chr6:37700590..37703118,2	K562	blood:
14	chr6:37665028..37669114-chr6:37674093..37676575,4	MCF-7	breast:
15	chr6:37650720..37654671-chr6:37670149..37673658,3	MCF-7	breast:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ZFAND3-6	chr6:37672600-37674014	NONHSAT112283

No data

Variant related genes	Relation type
ENSG00000112139	chromatin interactions

Extended variants
information (count: 475 )
Associated
traits (count: 90 )

Variant overlapped rSNPs/rCNVs (count:475 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs143573808	chr6:37672690-37672691	Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
2	rs368964989	chr6:37672746-37672747	Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
3	rs567891947	chr6:37672747-37672748	Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
4	rs184334798	chr6:37672758-37672759	Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
5	rs189184071	chr6:37672802-37672803	Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
6	rs558121897	chr6:37672812-37672813	Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
7	rs182226419	chr6:37672872-37672873	Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
8	rs376600595	chr6:37672942-37672943	Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
9	rs538922579	chr6:37672965-37672966	Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
10	rs149418646	chr6:37672993-37672994	Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
11	rs577189645	chr6:37673015-37673016	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
12	rs550860034	chr6:37673052-37673053	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
13	rs187144428	chr6:37673060-37673061	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
14	rs553443879	chr6:37673062-37673063	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
15	rs539749545	chr6:37673098-37673099	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
16	rs573547526	chr6:37673115-37673116	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
17	rs7767232	chr6:37673142-37673143	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region lncRNA	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs562504482	chr6:37673165-37673166	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
19	rs192487846	chr6:37673186-37673187	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
20	rs372587958	chr6:37673205-37673206	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
21	rs112080778	chr6:37673276-37673277	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
22	rs552886848	chr6:37673309-37673310	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
23	rs566698443	chr6:37673310-37673311	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
24	rs535536877	chr6:37673312-37673313	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
25	rs181523312	chr6:37673327-37673328	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
26	rs527672390	chr6:37673340-37673341	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
27	rs547949963	chr6:37673341-37673342	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
28	rs555444087	chr6:37673382-37673383	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
29	rs565931813	chr6:37673424-37673425	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
30	rs562701526	chr6:37673425-37673426	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
31	rs530089930	chr6:37673428-37673429	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
32	rs550355783	chr6:37673430-37673431	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
33	rs570116786	chr6:37673460-37673461	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
34	rs539339246	chr6:37673497-37673498	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
35	rs13213947	chr6:37673535-37673536	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
36	rs376367467	chr6:37673543-37673544	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
37	rs13213960	chr6:37673570-37673571	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
38	rs568559699	chr6:37673573-37673574	Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
39	rs552572176	chr6:37673605-37673606	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
40	rs73415451	chr6:37673644-37673645	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs377051137	chr6:37673645-37673646	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
42	rs75080669	chr6:37673656-37673657	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
43	rs573410952	chr6:37673693-37673694	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
44	rs535936059	chr6:37673706-37673707	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
45	rs141833671	chr6:37673720-37673721	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
46	rs531792502	chr6:37673734-37673735	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
47	rs545244397	chr6:37673736-37673737	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
48	rs576136835	chr6:37673738-37673739	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
49	rs77082754	chr6:37673742-37673743	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
50	rs117208178	chr6:37673755-37673756	Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:90)

Disease	PMID	Source
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Melanoma	18172304	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Hepatocellular carcinoma	16750200	CNVD
Autism	22495311	CNVD
Cancer	16790693	CNVD
Cervical cancer	21062161	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Cleidocranial dysplasia	18696259	CNVD
Holoprosencephaly	21359414	CNVD
Liposarcoma	21253554	CNVD
Uveal melanoma	20484589	CNVD
Fibroblasts	20926602	CNVD
Osteosarcoma	16790693	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Cancer	22183965	CNVD
Melanoma	22183965	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Lung cancer	18438408	CNVD
Glioblastoma multiforme	21138945	CNVD
Breast cancer	21364760	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Lung cancer	19153074	CNVD
Ovarian cancer	21720365	CNVD
Melanoma	21693616	CNVD
Myelofibrosis	22110671	CNVD
Mental retardation	21062444	CNVD
Breast cancer	16397240	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Osteosarcoma	21197465	CNVD
Gastric cancer	24379144	CNVD
Neuroblastoma	18923191	CNVD
abnormal development	18461090	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:554 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:37667200-37672800	Weak transcription	Right Atrium	heart
2	chr6:37667400-37672800	Enhancers	Primary hematopoietic stem cells short term culture	blood
3	chr6:37667400-37672800	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
4	chr6:37667600-37672800	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
5	chr6:37667600-37672800	Weak transcription	Pancreas	Pancrea
6	chr6:37667800-37672800	Weak transcription	Spleen	Spleen
7	chr6:37668000-37672800	Weak transcription	Adipose Nuclei	Adipose
8	chr6:37668000-37672800	Weak transcription	Brain Hippocampus Middle	brain
9	chr6:37668200-37672800	Weak transcription	Right Ventricle	heart
10	chr6:37669400-37672800	Weak transcription	Fetal Brain Male	brain
11	chr6:37669600-37672800	Weak transcription	Primary hematopoietic stem cells	blood
12	chr6:37669600-37672800	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
13	chr6:37669600-37672800	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
14	chr6:37671600-37672800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
15	chr6:37671800-37672800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
16	chr6:37671800-37672800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
17	chr6:37671800-37672800	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
18	chr6:37671800-37672800	Enhancers	Skeletal Muscle Female	skeletal muscle
19	chr6:37671800-37673200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
20	chr6:37671800-37674000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
21	chr6:37672000-37672800	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
22	chr6:37672000-37672800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
23	chr6:37672000-37672800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
24	chr6:37672000-37672800	Enhancers	Fetal Muscle Trunk	muscle
25	chr6:37672000-37672800	Enhancers	Fetal Muscle Leg	muscle
26	chr6:37672000-37672800	Enhancers	Fetal Stomach	stomach
27	chr6:37672000-37672800	Enhancers	K562	blood
28	chr6:37672000-37672800	Enhancers	NH-A	brain
29	chr6:37672000-37673200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
30	chr6:37672200-37672800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
31	chr6:37672200-37672800	Enhancers	Primary B cells from peripheral blood	blood
32	chr6:37672200-37672800	Enhancers	Ovary	ovary
33	chr6:37672200-37672800	Enhancers	Skeletal Muscle Male	skeletal muscle
34	chr6:37672400-37672800	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
35	chr6:37672400-37672800	Enhancers	Primary T helper cells fromperipheralblood	blood
36	chr6:37672400-37672800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
37	chr6:37672400-37672800	Enhancers	Cortex derived primary cultured neurospheres	brain
38	chr6:37672400-37673000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
39	chr6:37672600-37672800	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
40	chr6:37672600-37672800	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
41	chr6:37672600-37672800	Enhancers	Breast Myoepithelial Primary Cells	Breast
42	chr6:37672600-37672800	Enhancers	Primary B cells from cord blood	blood
43	chr6:37672600-37672800	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
44	chr6:37672600-37672800	Enhancers	Primary T helper naive cells from peripheral blood	blood
45	chr6:37672600-37672800	Enhancers	Primary T helper cells PMA-I stimulated	--
46	chr6:37672600-37672800	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
47	chr6:37672600-37672800	Enhancers	Muscle Satellite Cultured Cells	--
48	chr6:37672600-37672800	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
49	chr6:37672600-37672800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
50	chr6:37672600-37672800	Enhancers	Liver	Liver

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links